BioCardia, Inc. — Director's Dealing 2019

Aug 8, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BioCardia, Inc. (BCDA;BCDAW)
CIK: 0000925741
Period of Report: 2019-07-05

Reporting Person: Altman Peter (Director, President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-08-06	Common Stock	C	67484	$3	Acquired	153311	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-07-05	Convertible promissory note	$8	P		Acquired	2020-01-05	Common Stock (25000)	Direct
2019-08-06	Convertible promissory note	$3	C		Disposed	2020-01-05	Common Stock (67484)	Direct
2019-08-06	Warrant (right to buy)	$6.30	P	67484	Acquired	2024-08-06	Common Stock (67484)	Direct

Footnotes

F1: These securities were issued upon automatic conversion of a Convertible Promissory Note (the "Note") purchased pursuant to a Note Purchase Agreement dated July 5, 2019, by and between the Issuer and certain investors. The principal and accrued and unpaid interest on the Note was immediately convertible into shares of common stock at $8.00 per share or, if the Note remained outstanding at the time of the closing of a public offering of the Registrant, was subject to conversion into the securities offered in the public offering at 50% of the price to the public for such securities in such offering. The Registrant closed a public offering of units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock on August 6, 2019 at a price of $6.00 per unit and the Note converted in accordance with its terms into units at a price of $3.00 per unit.